“…In developed countries, the prevalence of MetS has risen up to 20–25% in the adult population, and its incidence continues to increase over time [ 5 , 6 , 7 , 8 ]. In Spain, the prevalence of MetS is currently reaching epidemic proportions, affecting approximately 22.7% of the population, taking into account that its incidence increases with age [ 5 ]. In addition, MetS increases the risk of T2DM onset and major cardiovascular events by two-fold and five-fold, respectively, and other chronic disease such as cancer, neurodegenerative diseases, non-alcoholic fatty liver disease, the risk of reproductive, lipid and circulatory disorders, atherosclerosis, and all cause-mortality are also increased [ 8 , 9 , 10 , 11 , 12 , 13 ].…”